Skip to main content
S.M.A.I.O logo

S.M.A.I.O — Investor Relations & Filings

Ticker · ALSMA ISIN · FR0014005I80 LEI · 969500T1Z0DAZXPZMC93 PA Manufacturing
Open in API
Filings indexed 118 across all filing types
Latest filing 2026-05-12 Earnings Release
Country FR France
Listing PA ALSMA

About S.M.A.I.O

https://smaio.com/

S.M.A.I.O. (Software, Machines and Adaptative Implants in Orthopaedics) is a medical device manufacturer that develops solutions for spine surgery. The company provides a comprehensive platform, I-Kontrol, which incorporates planning software, adaptive implants, and related services for spine surgeons. This integrated solution is designed to enhance control over surgical procedures to improve safety, performance, and repeatability. The I-Kontrol platform covers the entire surgical workflow, including pre-operative planning (i-PLAN), surgical execution with implants (i-PERFORM), post-operative outcome analysis (i-CHECK), and training programs (i-LEARN). S.M.A.I.O. utilizes clinical data, imaging, and artificial intelligence to advance the treatment of vertebral conditions.

Recent filings

Filing Released Lang Actions
Quarterly financial reporting / First quarter financial report
Earnings Release Classification · 90% confidence The document is a press release announcing first quarter 2026 revenue highlights (amounts, year-over-year changes, regional breakdowns) and upcoming financial events. It provides key results only and not a full interim report with full financial statements. This matches the definition of an Earnings Release. Q1 2026
2026-05-12 English
Information financière trimestrielle / Information financière du premier trimestre
Earnings Release Classification · 88% confidence The document is a press release announcing the company’s first quarter 2026 revenue results with headline figures, percentage changes, and management commentary. It does not contain full financial statements or detailed financial tables beyond summary metrics. This matches the definition of an Earnings Release (initial announcement of quarterly/periodical financial results). Q1 2026
2026-05-12 French
Informations privilégiées / Autres communiqués
Share Issue/Capital Change Classification · 75% confidence The document is a press release (“communiqué de presse”) announcing the nomination of Dr. Jeffrey M. Hills to SMAIO’s North American Scientific Council and detailing his remuneration via the issuance of bons de souscription d’actions (BSA). While it includes an advisory appointment, the annexed section focuses on the issuance of warrants, a corporate action involving a new securities issuance under a board‐delegated authorization. This fits the definition of a Share Issue/Capital Change announcement rather than a pure management change or generic regulatory notice. Therefore, the filing is best classified under Share Issue / Capital Change (SHA).
2026-05-11 French
Inside Information / Other news releases
Board/Management Information Classification · 65% confidence The document is a corporate press release announcing the appointment of Dr. Jeffrey M. Hills to SMAIO’s North American Scientific Advisory Board along with details of his remuneration via share subscription warrants. This is an announcement of a change in the company's advisory/management structure, falling under Board/Management Information (MANG).
2026-05-11 English
Inside Information / Other news releases
Regulatory Filings
2026-05-05 English
Informations privilégiées / Autres communiqués
Regulatory Filings
2026-05-05 French

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.